Yes, this can't be understated. Survey of 400 physicians!
This is a huge validation of how successful this test could be as a gold standard once all regulatory approvals and rebates are put into place.
As we all know this study was a key requirement for the Medicare rebates, another item ticked off the list as we get ever closer to actual commercialisation.
Just awesome!
Ann: Clinical utility study shows benefit of PromarkerD testing, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $58.62K | 150.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12180 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 5203 | 1 |
View Market Depth
| Last trade - 15.42pm 08/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |